Muhammad Junaid Anwar | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. Muhammad Junaid Anwar | Immunology Cellular Interactions | Best Researcher Award

Mr. Muhammad Junaid Anwar , Bahauddin Zakariya Univeristy Multan Pakistan , Pakistan

Dr. Muhammad Junaid Anwar is a dedicated food scientist specializing in Food Science and Technology. With a Ph.D. from Bahauddin Zakariya University (BZU), Multan, he has established himself as a researcher with expertise in food safety, nanotechnology, and functional foods. His work focuses on developing innovative solutions for food security, nutrition, and disease prevention. Having authored multiple high-impact research publications, Dr. Anwar’s contributions span across nanotechnology-based food encapsulation, food safety enhancement, and alternative protein sources. He has also participated in prestigious conferences and workshops, further showcasing his commitment to advancing food science. His research has significantly contributed to tackling food-related health challenges such as cow milk allergies, microbial contamination, and nutraceutical applications. With his profound knowledge, industry experience, and research excellence, Dr. Anwar stands out as a promising scholar in the field. His dedication to food innovation makes him a deserving candidate for the Best Researcher Award.

Publication Profile: 

Scopus

Strengths for the Award

  1. Strong Academic Background – Dr. Muhammad Junaid Anwar has an exceptional academic record with a Ph.D. in Food Science and Technology, a strong CGPA, and an extensive research focus.

  2. High-Impact Research Publications – He has authored multiple research articles in reputable, high-impact factor journals (Ultrasonics Sonochemistry, Food Science & Nutrition, Food Bioscience, etc.). His contributions cover diverse areas, including nanotechnology, food safety, and immunomodulation.

  3. Diverse Research Contributions – His research spans crucial topics such as nano-encapsulation, diabetes management, functional foods, and nutraceuticals, demonstrating interdisciplinary expertise.

  4. Industry Experience – His experience as an Officer in Quality Enhancement and Laboratory at S.M. Food Makers highlights his applied knowledge and practical contribution to food science.

  5. Conference Participation – He has actively contributed to scientific discussions through multiple national conferences, particularly on food security and food safety.

  6. Published Abstracts & Workshops – His engagement in published abstracts and workshops reflects an effort to bridge academia with real-world food technology applications.

Areas for Improvement

  1. International Collaboration – While his research is strong, expanding collaborations with international institutions and researchers could further enhance global impact.

  2. Patent & Commercialization – Translating research into patents or commercial food innovations would strengthen his practical contributions to the industry.

  3. Citations & Recognition – As some of his latest research articles have yet to gain citations, increasing visibility through academic networks and outreach can boost recognition.

Education:

Dr. Muhammad Junaid Anwar has an exceptional academic background in Food Science and Technology. He is currently completing his Ph.D. (2021-2025) at the Department of Food Science and Technology, BZU Multan, with a stellar CGPA of 3.87/4.00. Previously, he completed his M.Sc. (Hons.) in Food Science & Technology (2018-2020) from the same institution, securing a CGPA of 3.76/4.00. His undergraduate journey began with a B.Sc. (Hons.) in Agriculture (Food Science & Technology) (2014-2018), again with a CGPA of 3.76/4.00. His solid foundation in sciences started with F.Sc. (Pre-Medical) in 2014 from Muslim Public Higher Secondary School, Multan, achieving 840/1100 marks, followed by Matriculation in 2012 from Govt. M.A Jinnah High School, Multan, with 863/1050 marks. His consistent academic excellence highlights his dedication to food science research and technological advancements, making him a strong candidate for the Best Researcher Award.

Experience:

Dr. Muhammad Junaid Anwar has a diverse professional background in food science research and industry. He completed a 7-week internship at Bunny’s Limited, Lahore, where he gained hands-on experience in food processing and quality control. He later served as an Officer (Quality Enhancement and Lab) at S.M. Food Makers for two years (2018-2020), where he worked on ensuring food safety standards and enhancing product quality. His industry experience has provided him with a deep understanding of food technology applications, quality assurance, and research methodologies. In addition to his industry roles, he has contributed to academia through extensive research on food nanotechnology, functional foods, and microbial safety. His experience spans both applied and theoretical research, making him an asset to the food science community. His professional achievements, combined with his research excellence, make him a strong contender for the Best Researcher Award.

Research Focus:

Dr. Muhammad Junaid Anwar’s research revolves around food nanotechnology, functional foods, and food safety. His recent work focuses on the nano-encapsulation of bioactive compounds, such as casein-based encapsulation for managing cow milk allergies. His contributions extend to food safety enhancements using ultrasonication and calcium chloride treatments to reduce microbial contamination in fresh produce. Dr. Anwar has also explored the nutraceutical applications of medicinal plants like fenugreek and Tribulus terrestris to develop functional foods with health benefits. His studies have highlighted the role of alternative protein sources, such as Moringa oleifera-derived proteins, in plant-based meat substitutes. Additionally, he has worked on the impact of ozone treatment in mitigating mycotoxin contamination in food. His multi-disciplinary approach to food science integrates biotechnology, food engineering, and health sciences, making his research valuable for global food security and human health. His outstanding contributions make him a strong candidate for the Best Researcher Award.

Publications Top Notes:

📌 Casein-Based Nano-Encapsulation for Cow Milk Allergy Management 🥛🔬 (Food Bioscience, 2025)
📌 Ultrasonication & Calcium Chloride Pre-Treatment for Microbial Load Reduction in Carrots 🥕🦠 (Ultrasonics Sonochemistry, 2025)
📌 Isoflavones: Natural Agents for Cancer Prevention & Treatment 🎗️🍃 (Food Science & Nutrition, 2025)
📌 Functional Yogurt with Cinnamon & Stevia for Diabetes Management 🍦🍯 (Food & Agricultural Immunology, 2024)
📌 Nutritional & Physico-Chemical Profiling of Tribulus terrestris for Nutraceutical Applications 🌿💊 (Journal of Population Therapeutics & Clinical Pharmacology, 2024)
📌 The Multifaceted Potential of Fenugreek Seeds in Health & Nanotechnology 🌱⚗️ (Food Science & Nutrition, 2024)
📌 Protein Extraction from Moringa Leaves as a Plant-Based Meat Alternative 🍃🥩 (Regulatory Toxicology & Pharmacology, 2024)
📌 Role of Ozone in Mycotoxin Management for Food Safety ⚡🍞 (PSFST Conference, 2023)
📌 Potential of Anaerobic Digestion in Food Waste Management 🔄♻️ (PSFST Conference, 2023)
📌 Addressing Food Price Fluctuations: A Global Priority 📈🌍 (PSFST Conference, 2023)
📌 Strengthening Local Food Systems for Food Security 🌾🍽️ (PSFST Conference, 2023)

Conclusion:

Dr. Muhammad Junaid Anwar has demonstrated exceptional research contributions in food science, particularly in functional foods, nanotechnology, and food safety. His high-impact publications, active participation in conferences, and industry experience make him a strong candidate for the Best Researcher Award. Strengthening international collaborations and focusing on patents or commercialization could further enhance his research impact.

Marcio Rodrigues | Microbial Cell Biology | Pioneer Researcher Award

Published on by Cell Biologist

Dr. Marcio Rodrigues | Microbial Cell Biology | Pioneer Researcher Award

Dr. Marcio Rodrigues , Fiocruz , Brazil

Dr. Marcio L. Rodrigues is a distinguished Senior Investigator at the Carlos Chagas Institute of Fiocruz, specializing in fungal infections. His pioneering work in fungal extracellular vesicles (EVs) has revolutionized the understanding of fungal secretion mechanisms and antifungal drug development. With an extensive background in microbiology and pharmaceutical sciences, Dr. Rodrigues has made groundbreaking contributions to Cryptococcus research. He has held editorial roles at prestigious journals, coordinated major research programs, and received numerous accolades, including a Fellowship at the Brazilian Academy of Sciences. His research has significantly impacted global fungal disease studies, earning him recognition as a leader in the field.

Publication Profile:

Orcid

Strengths for the Award:

✅ Pioneering Contributions – Dr. Rodrigues has significantly advanced fungal microbiology, particularly in the field of fungal extracellular vesicles (EVs), a groundbreaking area of study.
✅ Extensive Research Output – His prolific publication record in high-impact journals like Nature Microbiology and mBio reflects the depth of his contributions.
✅ Leadership & Editorial Roles – His position as an editor for Current Topics in Microbiology and Immunology and ASM’s mBio demonstrates his influence in the scientific community.
✅ International Recognition – His fellowships and awards, including the Wellcome Trust Pathfinder Award and recognition by The World Academy of Science (TWAS), highlight his global impact.
✅ Funding & Program Coordination – As a coordinator of the Inova Funding Program at Fiocruz, he plays a crucial role in fostering research and innovation.

Areas for Improvement:

🔹 Industry Collaboration – While his research is academically impactful, expanding collaborations with biotechnology and pharmaceutical companies could enhance the translational applications of his findings.
🔹 Public Outreach & Policy Advocacy – Increasing public engagement and involvement in global health policy discussions on fungal infections would further solidify his influence beyond academia.
🔹 Interdisciplinary Expansion – Bridging fungal biology with AI-driven bioinformatics or immunotherapy could push his research into newer frontiers.

Education:

🎓 Federal University of Rio de Janeiro
🔹 PHMD (1995) – Pharmaceutical Sciences
🔹 PhD (2000) – Microbiology

Dr. Rodrigues pursued his higher education at the Federal University of Rio de Janeiro, obtaining a PHMD in Pharmaceutical Sciences in 1995. He further specialized in Microbiology, completing his PhD in 2000. His academic training provided a strong foundation for his career in medical mycology, particularly in studying fungal pathogens. His doctoral research focused on the biology of Cryptococcus neoformans, paving the way for his later work in fungal extracellular vesicles (EVs) and their role in pathogen virulence and drug resistance.

Experience:

🔬 Senior Investigator, Carlos Chagas Institute, Fiocruz
📖 Editor, Current Topics in Microbiology and Immunology (Springer)
📝 Mini-review Editor, ASM’s mBio
💡 Coordinator, Inova Funding Program, Fiocruz

With over two decades of research experience, Dr. Rodrigues has established himself as a global leader in fungal biology and infectious diseases. As a Senior Investigator at Fiocruz, he leads studies on fungal EVs, antifungal resistance, and molecular microbiology. His editorial roles in high-impact journals underscore his expertise in the field, while his coordination of research funding programs demonstrates his commitment to advancing mycology research.

Awards & Honors:

🏆 Pathfinder Award (2014-2016) – The Wellcome Trust, UK
🌍 Young Affiliate (2011-2015) – The World Academy of Science (TWAS)
🇧🇷 Fellow (2024) – Brazilian Academy of Sciences

Dr. Rodrigues has received prestigious awards for his contributions to fungal pathogenesis and drug discovery. His recognition as a Pathfinder Awardee by The Wellcome Trust and a Young Affiliate of TWAS highlights his impact on global infectious disease research. In 2024, he was elected a Fellow of the Brazilian Academy of Sciences, reinforcing his standing as a leading researcher in microbiology.

Research Focus:

🦠 Fungal Extracellular Vesicles (EVs)
💊 Antifungal Drug Discovery
🔬 Cryptococcus neoformans Pathogenesis
🧫 Molecular Mechanisms of Fungal Infections

Dr. Rodrigues’ research has been instrumental in uncovering the role of fungal EVs in pathogen virulence and host interactions. His work has led to novel insights into fungal secretion mechanisms and drug resistance, contributing to the development of new antifungal therapies. His studies on Cryptococcus species have provided crucial data for the medical mycology field, enhancing diagnostic and therapeutic strategies for fungal infections.

Publications Top Notes:

📜 Proteomics reveals that the antifungal activity of fenbendazole against Cryptococcus neoformans requires protein kinases – International Journal of Antimicrobial Agents, 2024
📜 Screening of the Pandemic Response Box reveals an association between antifungal effects of MMV1593537 and the fungal cell wall – Microbiol Spectr, 2022
📜 A general analysis of the impact of international collaboration on scientific citations – Anais da Academia Brasileira de Ciências, 2025
📜 Characterizing extracellular vesicles of human fungal pathogens – Nature Microbiology, 2025
📜 Introducing mGems, mBio’s new review type – mBio, 2025
📜 Effects of human immunoglobulin A on Cryptococcus neoformans morphology and gene expression – Microbiology Spectrum, 2025
📜 Preparation of biologically active fractions enriched with glucuronoxylomannan, the main antigen of the cryptococcal capsule – 2024 (Book Chapter)
📜 Extracellular Vesicles from Scedosporium apiospermum and fungal-host interactions – Journal of Fungi, 2024
📜 Funding for research on cryptococcal disease: an analysis based on the G-finder report – IMA Fungus, 2024
📜 The multiple frontiers in the study of fungal extracellular vesicles – Microbes and Infection, 2024
📜 A tribute to Professor Luiz R. Travassos: Lessons from a scientist (1938–2020) – Brazilian Journal of Microbiology, 2023

Conclusion:

Dr. Marcio L. Rodrigues is an exceptionally strong candidate for the Pioneer Researcher Award due to his groundbreaking discoveries, prolific publication record, leadership roles, and international recognition. His work on fungal extracellular vesicles and antifungal development has significantly shaped the field, making him a deserving recipient of this prestigious award.

Robert Crawford | Gene Regulation Epigenetics | Epigenetics in Cell Biology Award

Published on by Cell Biologist

Dr. Robert Crawford | Gene Regulation Epigenetics | Epigenetics in Cell Biology Award

Dr. Robert Crawford, biomodal , United Kingdom

Dr. Robert Crawford, MEng, DPhil (Oxon), is a distinguished multi-disciplinary scientist and engineer with over 13 years of experience in the life sciences. His expertise spans the development, integration, and verification of DNA sequencing technologies, with a strong focus on genomic and epigenomic applications. He currently serves as Associate Director of Collaborations and Applications at biomodal, where he leads scientific and informatics teams to drive innovation and strategic partnerships. Previously, he played a key role at Illumina in integrating whole-genome sequencing solutions for in vitro diagnostics. Dr. Crawford’s academic journey began at the University of Oxford, where he earned a DPhil in Condensed Matter Physics and contributed to the foundational IP of Oxford Nanoimaging. His research has led to multiple high-impact publications, patents, and conference presentations. Passionate about scientific discovery and translational research, he continues to shape the future of epigenetics and molecular diagnostics.

Publication Profile: 

Orcid

Strengths for the Award:

✅ Expertise in Epigenetics & Genomics – Dr. Robert Crawford has extensive experience in genomic and epigenomic sequencing, particularly in integrating DNA modifications like 5-methylcytosine and 5-hydroxymethylcytosine as biomarkers. His recent publications in Nature Structural & Molecular Biology demonstrate his contributions to the field.

✅ Industry & Academic Impact – His transition from academia to industry has resulted in high-impact research, patents, and product development. At biomodal, he leads teams working on sequencing applications relevant to cell biology and epigenetics.

✅ Innovation & Translational Research – He co-invented a single-molecule microscope (now a spin-out, Oxford Nanoimaging), showcasing his ability to translate fundamental research into real-world applications.

✅ Collaborative Leadership – His role at biomodal involves leading collaborations with academic and commercial partners, demonstrating his ability to foster research in epigenetics and molecular diagnostics.

Areas for Improvement:

🔹 Further Independent Research – While his collaborative research is significant, leading an independent research program in epigenetics would further strengthen his case for this award.
🔹 Expanded Focus on Cell Biology Applications – While his work heavily focuses on DNA modifications, a deeper exploration into how these modifications impact broader cellular mechanisms could enhance his profile.

Education:

Dr. Robert Crawford obtained his DPhil (Oxon) in Condensed Matter Physics from St John’s College, University of Oxford, where he investigated single-molecule DNA sensors and transcription factor dynamics. His research was conducted under the supervision of Prof. Achilles Kapanidis in the Gene Machines Group. Prior to his doctorate, he completed interdisciplinary training at Oxford’s Life Sciences Interface Doctoral Training Centre, covering computational biology, medical imaging, biophysics, and bioinformatics. His undergraduate education culminated in an MEng in a related field, equipping him with strong analytical and engineering skills. Dr. Crawford’s academic foundation has been instrumental in his contributions to DNA sequencing technologies, super-resolution imaging, and epigenetics. His work at Oxford also led to the invention of a compact single-molecule microscope, which later became the basis for the spin-out Oxford Nanoimaging. His rigorous scientific background enables him to bridge fundamental research and commercial biotechnology applications.

Experience:

Dr. Robert Crawford’s professional career has spanned academia and industry, with a focus on genomics, epigenetics, and molecular diagnostics. At biomodal, he serves as Associate Director of Collaborations and Applications, leading teams in commercial and academic partnerships, technology demonstrations, and strategic initiatives. Previously, he spent nearly a decade at Illumina, where he played a key role in integrating end-to-end in vitro diagnostic whole-genome sequencing solutions. His expertise in troubleshooting, large-scale data analysis, and verification test planning has contributed to the successful deployment of cutting-edge sequencing platforms. In academia, he was a Research Fellow at the University of Oxford, pioneering single-molecule imaging techniques and co-inventing a compact microscope for biosensing. This work laid the groundwork for Oxford Nanoimaging, now a leading biotech company. Dr. Crawford’s blend of research innovation and industry execution has made him a driving force in the advancement of sequencing technologies.

Awards and Honors:

Dr. Robert Crawford has received several prestigious awards and research grants in recognition of his contributions to life sciences and engineering. In 2013, he was awarded a Junior Research Fellowship at Linacre College, University of Oxford, supporting his groundbreaking work in single-molecule microscopy. His postdoctoral research attracted over £160,000 in funding, including a £120,000 DSTL grant from the UK Ministry of Defence, a £10,000 BBSRC Sparking Impact award, and an EPSRC PhD Plus Scholarship worth £24,000. Additionally, he secured BBSRC Follow-on Funding through the Pathfinder scheme (£10,000) to advance the commercialization of his research. His patented work on compact microscopy led to the founding of Oxford Nanoimaging, which has raised over $109.4 million in funding. Through these achievements, Dr. Crawford has demonstrated a consistent ability to translate high-impact research into real-world applications, making him a strong contender for the Research for Epigenetics in Cell Biology Award.

Research Focus:

Dr. Robert Crawford’s research centers on the intersection of genomics, epigenetics, and molecular diagnostics, with a particular emphasis on developing and optimizing sequencing technologies. His work at biomodal explores the synergistic role of DNA modifications, such as 5-methylcytosine and 5-hydroxymethylcytosine, as biomarkers for early cancer detection. His recent studies highlight the critical regulatory function of OGT in global DNA methylation and transposable element suppression, advancing the understanding of epigenomic stability. During his time at Oxford, he developed a single-molecule fluorescence microscope for studying intracellular transcription factors, leading to significant breakthroughs in live-cell imaging. His research has been widely published in top-tier journals and has contributed to the development of cutting-edge sequencing workflows. With a strong commitment to translational science, Dr. Crawford’s work continues to push the boundaries of epigenetic research, making impactful contributions to early disease detection and precision medicine.

Publications Top Notes:

📌 2025 – 5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer – Nat Struct Mol Biol
🧬 2025 – OGT is a key regulator of global DNA methylation – Nat Struct Mol Biol
🧬 2025 – OGT prevents DNA demethylation and suppresses transposable elements in heterochromatin – Nat Struct Mol Biol (Accepted)
🔬 2015 – Compact Microscope – WO 2015059682 A1 (Founding IP for Oxford Nanoimaging)
💡 2013 – Long Lived Intracellular Single-molecule Fluorescence Using Electroporated Molecules – Biophys. J.
🧬 2013 – Non-covalent Single Transcription Factor Encapsulation Inside a DNA Cage – Angew Chem.

Conclusion:

Dr. Robert Crawford is an outstanding candidate for the Research for Epigenetics in Cell Biology Award due to his extensive expertise in genomic and epigenomic sequencing, strong research track record, and ability to bridge fundamental science with commercial applications. With his leadership in sequencing technology development and impactful publications, he is well-positioned to make continued contributions to epigenetics and cell biology. 🚀

Ahmet Kor | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Ahmet Kor | Immunology Cellular Interactions | Best Researcher Award

Assoc. Prof. Dr. Ahmet Kor , aksaray university training and research hospital , Turkey

Dr. Ahmet Kor is an associate professor at the Department of Rheumatology, Aksaray Education and Research Hospital, Turkey. With a profound expertise in rheumatology, he has made significant contributions to biomarker-based research in various rheumatological diseases. Dr. Kor is well-known for his pioneering work in understanding the relationship between rheumatoid arthritis (RA) and interstitial lung disease, as well as his research on small vessel vasculitis and renal estrogen receptors. His work is highly regarded for its originality and depth in the study of biomarkers and disease mechanisms. Dr. Kor’s academic journey has seen him publish numerous journal articles, collaborate with global researchers, and gain recognition in the field. He is committed to advancing rheumatology research and improving clinical outcomes for patients with autoimmune diseases.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Ahmet Kor’s impressive body of work in rheumatology, particularly his focus on biomarkers, places him as an ideal candidate for the “Best Researcher Award.” He has contributed significantly to understanding complex mechanisms in autoimmune diseases such as rheumatoid arthritis (RA) and primary Sjögren’s syndrome. Notably, his pioneering research into the relationship between RA and interstitial lung disease, as well as his exploration of estrogen receptors in small vessel vasculitis, has opened new avenues for diagnostics and treatment. With a remarkable publication record, Dr. Kor has demonstrated both depth and breadth in his research, having published 17 peer-reviewed articles in SCI-indexed journals. His research also bridges the gap between clinical practice and scientific exploration, which enhances its relevance. His ability to identify novel biomarkers like netrin-1 in various diseases showcases his innovative thinking and commitment to advancing rheumatology.

Areas for Improvements:

While Dr. Kor’s research is highly impactful, expanding the focus of his work to include larger-scale clinical trials could provide additional validation of his findings in broader populations. Furthermore, enhancing collaborations with research institutions worldwide could increase the global applicability of his discoveries. A more extensive exploration into therapeutic implications of his findings may also contribute significantly to clinical advancements.

Education:

Dr. Ahmet Kor completed his medical degree (MD) at a prestigious university in Turkey, focusing on the field of rheumatology. He then pursued specialized training and completed his residency in internal medicine before further refining his expertise in rheumatology. His educational background allowed him to develop a deep understanding of autoimmune diseases, particularly their biomarkers and disease progression. Throughout his academic career, Dr. Kor has engaged in continuous education and research, publishing books and numerous peer-reviewed journal articles. His research interests have evolved into studying the molecular mechanisms underlying rheumatological diseases, contributing valuable knowledge to both the academic and clinical communities. Dr. Kor’s educational foundation combined with his professional training has solidified his status as a leading expert in rheumatology, and he continues to inspire students and colleagues alike through his work and teachings.

Experience:

Dr. Ahmet Kor has significant experience in both clinical practice and academic research in rheumatology. He currently holds the position of associate professor at Aksaray Education and Research Hospital in Turkey, where he leads a team of researchers in exploring biomarker-based studies for rheumatological diseases. Over the years, Dr. Kor has worked extensively in clinical settings, diagnosing and treating various autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and small vessel vasculitis. His extensive research portfolio spans multiple domains, from interstitial lung diseases to novel biomarkers for autoimmune diseases. Dr. Kor has been involved in consulting for the pharmaceutical industry and collaborated with other research institutions globally. His experience extends beyond clinical practice, as he actively contributes to scientific journals, editorial roles, and academic committees. His ability to bridge research with clinical application allows him to make lasting contributions to the field of rheumatology.

Research Focus:

Dr. Ahmet Kor’s research focuses on the exploration of biomarkers in rheumatology, particularly in autoimmune diseases such as rheumatoid arthritis (RA) and small vessel vasculitis. His work aims to identify novel biomarkers that can predict disease progression, diagnose early-stage diseases, and guide therapeutic interventions. He has made significant discoveries regarding the relationship between RA-associated interstitial lung disease and netrin-1 levels, as well as the connection between small vessel vasculitis and renal estrogen receptors. Additionally, Dr. Kor’s research delves into the molecular mechanisms of disease, such as the thiol/disulfide balance in psoriatic arthritis and the potential role of estrogen receptors in primary Sjögren’s syndrome. His studies are instrumental in advancing personalized medicine in rheumatology, with the aim of improving diagnostic accuracy and therapeutic outcomes. Through his interdisciplinary research, Dr. Kor seeks to make impactful contributions to the understanding of autoimmune diseases and their biomarkers.

Publications Top Notes:

  • Urinary Total Superoxide Dismutase Activity in Rheumatoid Patients 🔬🧬

  • Does Eta Protein Differentiate Rheumatoid Arthritis from Psoriatic Arthritis? 🤔💉

  • Renal Tubular Estrogen ß Receptors in Small Vessel Vasculitis 🧑‍🔬🔬

  • Thiol/Disulfide Balance in Psoriatic Arthritis 🧪🧬

  • Ensemble Learning and Feature Selection in Diagnosis of Low Back Pain 💻🩺

  • Serum Netrin-1 Level in Rheumatoid Arthritis 🧪🔬

  • Estrogen Receptor ß in Minor Salivary Glands of Primary Sjögren’s Syndrome 🧑‍🔬💉

  • Serum Netrin-1 as a Potential Biomarker for Diabetic Peripheral Artery Disease 🩸💉

  • 14-3-3η Proteins in Primary Sjögren Syndrome 🧬💡

Conclusion:

Dr. Ahmet Kor is a distinguished researcher whose contributions to the field of rheumatology, particularly in biomarker-based studies, make him highly deserving of the “Best Researcher Award.” His innovative approach to understanding complex autoimmune diseases, combined with his extensive publications and collaborations, reflects his dedication to improving patient care and advancing the scientific understanding of rheumatology. His research offers significant potential for future breakthroughs, making him an outstanding candidate for this prestigious award.

Pavan Kumar | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Pavan Kumar | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Pavan Kumar , Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, India

Dr. Pavan Kumar is an Assistant Professor at the Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, India. With a Ph.D. from the prestigious Indian Institute of Technology (IIT) Kanpur, Dr. Kumar has made significant contributions to biomedical research, focusing on head and neck cancer detection. His research integrates spectroscopic and imaging devices for non-invasive detection of oral and throat cancers. Dr. Kumar has published 8 journal articles and has contributed to two books. He is well-versed in applying machine learning tools, including PCA, LDA, SVM, and others, to improve cancer diagnosis. His work also involves developing portable devices for in-vivo testing. Dr. Kumar is dedicated to bridging the gap between technology and healthcare, demonstrating excellence in both research and teaching.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Pavan Kumar’s work in the field of head and neck cancer detection using innovative bio-photonics techniques is exemplary. His research focuses on non-invasive diagnostic methods, such as fluorescence spectroscopy, Stokes shift, and diffuse reflectance spectroscopy, which have significant potential in clinical applications for early cancer detection. He has developed portable, handheld devices for in-vivo testing of oral cancers, showcasing his innovation in medical technology. Dr. Kumar’s expertise in machine learning tools like PCA, LDA, and SVM for data classification demonstrates his ability to integrate advanced computational techniques into medical diagnostics. Additionally, his publication record, with 8 journal articles and several book chapters, reflects his dedication to advancing the field. Dr. Kumar has also collaborated with various researchers, further enhancing the depth of his work.

Areas for Improvement:

While Dr. Kumar’s research is highly focused and innovative, expanding his collaborations to include larger multidisciplinary teams or industry partnerships could provide additional avenues for technology transfer and real-world applications. Increasing the scope of his work to include other cancer types or medical conditions could broaden the impact of his research. Furthermore, engaging in more professional memberships and editorial roles could increase his visibility and influence within the global research community.

Education:

Dr. Pavan Kumar completed his Ph.D. in Biomedical Engineering from the Indian Institute of Technology (IIT) Kanpur in 2020. His doctoral research was focused on the development of spectroscopic and imaging techniques for the detection of head and neck cancer. Prior to his Ph.D., he completed a Master’s degree in Biomedical Engineering, gaining a solid foundation in both theoretical and practical aspects of medical technology. His academic journey also includes a postdoctoral position in the Department of Biomedical Engineering at IIT Ropar, where he continued to expand his expertise in the field of bio-photonics and cancer detection. Dr. Kumar’s educational background provided him with the tools to develop innovative methods in cancer diagnosis using fluorescence spectroscopy, Stokes shift, and diffuse reflectance techniques. His education laid the foundation for a career marked by both academic and research excellence.

Experience:

Dr. Pavan Kumar has over five years of experience in academic research, teaching, and development of diagnostic devices. After completing his Ph.D. from IIT Kanpur, Dr. Kumar worked as a postdoctoral fellow at IIT Ropar (January 2020 to January 2021) in the Department of Biomedical Engineering. During this period, he focused on cancer detection using advanced spectroscopic and imaging techniques. Since then, Dr. Kumar has been an active faculty member at the Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, where he teaches medical physics and coordinates project-based learning initiatives. His work combines cutting-edge technology with practical applications, such as in-vivo cancer detection using handheld devices. Dr. Kumar has published extensively in peer-reviewed journals, with his work focused on applying machine learning models to improve diagnostic accuracy. His contributions have significantly advanced the fields of biomedical engineering and bio-photonics.

Research Focus:

Dr. Pavan Kumar’s primary research focus lies in the development of advanced spectroscopic and imaging techniques for the early detection of head and neck cancers. Specifically, he has concentrated on fluorescence spectroscopy, Stokes shift (SS), and diffuse reflectance (DR) as non-invasive tools for diagnosing oral and throat cancers. His work includes the development of handheld, portable devices that use fluorescence for in-vivo testing of oral mucosal lesions. Dr. Kumar’s research also integrates machine learning algorithms, such as Principal Component Analysis (PCA), Linear Discriminant Analysis (LDA), and Support Vector Machines (SVM), to classify different stages of cancer and enhance diagnostic precision. Additionally, his exploration of human saliva as a diagnostic medium for cancer detection demonstrates his commitment to innovative, cost-effective solutions in healthcare. Through his interdisciplinary research, Dr. Kumar is pushing the boundaries of bio-photonics to provide accessible and accurate diagnostic tools for cancer detection.

Publications Top Notes:

  1. Detection of Oral Mucosal Lesions by Fluorescence Spectroscopy and Classification of Cancerous Stages by Support Vector Machine – Lasers in Medical Science (2024) 🔬📊

  2. Human Saliva as a Substitute Diagnostic Medium for the Detection of Oral Lesions Using Stokes Shift Spectroscopy – Asian Pacific Journal of Cancer Prevention (2023) 💧🦷

  3. In-vivo Testing of Oral Mucosal Lesions with an In-house Developed Portable Imaging Device and Comparison with Spectroscopy Results – Journal of Fluorescence (2023) 💡🔍

  4. Detection of Oral Cancer Using Fluorescence Spectroscopy and Classification of Different Stages of Cancer by Multivariate Analysis – ICETEMS Conference (2022) 🦷📉

  5. Fluorescence-Based Handheld Imaging Device for In-vivo Detection of Oral Precancer – Optics InfoBase (2021) 💡🖥️

  6. Porphyrin as a Biomarker for the Detection of COVID-19 Using Fluorescence Spectroscopy and Human Body Fluid Saliva – Applied Research Development (2021) 🦠🧪

  7. Fluorescence-Based Handheld Imaging Device for In-vivo Detection of Oral Precancer – Translational Biophotonics (2021) 💡📱

  8. Detection of Inaccessible Head and Neck Lesions Using Human Saliva and Fluorescence Spectroscopy – Lasers in Medical Science (2021) 👄🔬

  9. Human Tissue and Saliva as Diagnostic Media for Detection of Oral Cancer Using Stokes Shift Spectroscopy – Asian Journal of Physics (2020) 🔬🧪

  10. In Vivo Detection of Oral Precancer Using a Fluorescence-Based, In-House-Fabricated Device – Lasers in Medical Science (2019) 🦷💡

Conclusion:

Dr. Pavan Kumar is undoubtedly a highly deserving candidate for the Research for Best Researcher Award. His contributions to cancer detection, especially in head and neck cancers, using spectroscopy and machine learning, have the potential to revolutionize diagnostic methods. His innovative approach to bio-photonics and commitment to advancing medical technology make him an outstanding researcher in his field. With continued growth in collaboration and outreach, Dr. Kumar’s work has the potential to make a profound impact on global healthcare.

Kewalin Inthanon | Lipid Signaling Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Kewalin Inthanon | Lipid Signaling Biology | Best Researcher Award

Assist. Prof. Dr. Kewalin Inthanon , Thammasat University , Thailand

Dr. Kewalin Inthanon is an Assistant Professor at Thammasat University’s Faculty of Science and Technology in Lampang, Thailand. With a robust academic background, he holds a Ph.D. in Biology from Chiang Mai University and an M.Phil. in Clinical Neuroscience from the University of Cambridge. His expertise is in biotechnology, biochemistry, and the application of natural products and biomaterials to cellular and molecular research. Dr. Inthanon has contributed extensively to the study of cell cultures, oxidative stress, cellular senescence, and the effects of plant extracts, drugs, and biomaterials on cellular functions. His academic career is complemented by numerous research publications and successful research projects focusing on advancing the therapeutic potential of natural compounds and biocompatible materials. As a recognized researcher with notable expertise, he has become an influential figure in the fields of cellular biology and biotechnology.

Publication Profile: 

Orcid

Strengths for the Award

  1. Expertise and Research Focus: Dr. Inthanon has specialized expertise in biochemistry, biotechnology, and the integration of natural products with biomaterials. His research into cytotoxicity, oxidative stress, cellular senescence, and cellular responses to plant extracts, drugs, and biomaterials demonstrates a profound commitment to addressing both fundamental and applied scientific problems. His focus on stem cells, cancer cells, and natural compounds, particularly in the context of human cell cultures, is highly relevant to cutting-edge biotechnology.

  2. Publication Record: Dr. Inthanon’s extensive publication record includes high-impact journal articles in reputable journals like Scientific Reports, Chemistry of Natural Compounds, and Biocatalysis and Agricultural Biotechnology. His papers are well-cited, and he has co-authored several influential studies on the pharmacological and therapeutic properties of plant-derived compounds and biomaterials.

  3. Academic and Research Leadership: As an academic lecturer at Thammasat University and a postdoctoral researcher at Chiang Mai University, Dr. Inthanon demonstrates leadership in guiding the next generation of scientists. His involvement in multiple research projects and the administration of a major phytochemical analysis and bioactivity study on Dillenia indica L. shows his proactive approach to research development.

  4. Innovation and Collaborative Approach: Dr. Inthanon is an excellent collaborator, as seen in his contributions to multi-author publications and his involvement in collaborative projects across different research fields, such as bioengineering, cell culture systems, and plant-derived natural products. This collaborative nature reflects his ability to contribute effectively to both local and international scientific communities.

  5. Peer Review and Recognition: His participation as a peer reviewer for journals such as Food Science & Nutrition and Exploration of BioMat-X further underscores his credibility and recognition within the research community.

Areas for Improvement

  1. Expansion of Interdisciplinary Research: While Dr. Inthanon has done well in integrating natural products with biomaterials and biotechnology, further expansion into interdisciplinary research involving fields such as nanotechnology, synthetic biology, or environmental biotechnology could open up new avenues for innovation.

  2. Increased Public Outreach: Engaging in more public outreach or science communication could help Dr. Inthanon bridge the gap between academic research and broader societal impacts. This could involve more public lectures, writing for popular science outlets, or working with non-academic stakeholders (such as the pharmaceutical industry) to translate research into practical applications.

  3. Development of Commercializable Products: While Dr. Inthanon has demonstrated strong research on natural compounds and biomaterials, focusing on the development of commercializable biotechnological products, such as drugs or health supplements, could further highlight his potential for impactful, real-world applications.

Education:

Dr. Kewalin Inthanon completed his Bachelor of Science (BSc) and Master of Science (MSc) in Biology at Chiang Mai University, Thailand, where he developed a solid foundation in biological sciences. He later pursued an M.Phil. in Clinical Neuroscience at the University of Cambridge, UK, which furthered his understanding of the cellular mechanisms underlying diseases and therapies. Dr. Inthanon earned his Ph.D. in Biology from Chiang Mai University in 2015, specializing in biotechnology and biochemistry, with a focus on human and animal cell culture systems. His diverse educational background has enabled him to combine basic biological research with applied studies in the biomedical and biotechnological fields. Dr. Inthanon’s interdisciplinary education and training make him well-equipped to investigate the molecular and cellular effects of biomaterials, natural products, and therapies, making significant contributions to the field of cell biology and tissue engineering.

Experience:

Dr. Kewalin Inthanon has extensive experience as an academic lecturer at the Department of Biotechnology, Faculty of Science and Technology, Thammasat University, Lampang Campus, Thailand, since 2016. His academic work involves teaching and guiding students in the fields of biotechnology and biochemistry. Prior to his current role, Dr. Inthanon completed a postdoctoral fellowship in biomaterial and tissue engineering at Chiang Mai University from 2015 to 2016. This experience enabled him to specialize in bioengineering, stem cell research, and cellular responses to biomaterial scaffolds. His involvement in various collaborative research projects further honed his skills in experimental design and analysis, leading to numerous peer-reviewed publications. Additionally, Dr. Inthanon has played an essential role in managing and supervising projects focused on the development of natural products and biocompatible materials for therapeutic applications. His expertise in cell culture techniques, biomaterials, and natural products makes him a valuable asset to the research community.

Research Focus:

Dr. Kewalin Inthanon’s research primarily focuses on the intersection of biotechnology, biochemistry, and natural product science. His work explores the effects of plant extracts, drugs, natural compounds, and biomaterials on human cell cultures, including stem cells and cancer cells. He is particularly interested in the cellular responses to oxidative stress, cytotoxicity, cellular senescence, and the modulation of gene expression in the context of disease prevention and treatment. Dr. Inthanon’s research aims to unravel complex signaling pathways and the molecular mechanisms that underlie cellular activities when exposed to various bioactive substances. This research is particularly relevant in the fields of cancer therapy, aging, and regenerative medicine, where the therapeutic potential of natural products can provide novel approaches to disease treatment. Additionally, his work on biomaterials, especially in tissue engineering, emphasizes creating biocompatible scaffolds to support cellular growth and differentiation in medical applications.

Publications Top Notes:

  1. Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential 🧬💪

  2. Cytotoxic Constituents of the Fruits of Garcinia schomburgkiana 🍊💥

  3. Collagen‐cellulose‐poly (l‐lactide) scaffold by electrospinning and plasma‐assisting fabrication for bone tissue engineering applications 🦴🔬

  4. Phytochemical Profiles and Anticancer Effects of Calophyllum inophyllum L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung Cancers 🌿🦠

  5. In vitro assessment of antioxidant and anti-aging properties of ethanol extracts from Amaranthus dubius, Perilla frutescens (L.) britton, and Phyllanthus emblica 🌱⏳

  6. Identification of highly potent α-glucosidase inhibitors from Garcinia schomburgkiana and molecular docking studies 🧪🧠

  7. Sequencerelated amplified polymorphism (SRAP) molecular marker: DNA fingerprinting studying on economic and agricultural earthworms in North of Thailand 🧬🐍

  8. Chemical Constituents of the Stem Bark of Bombax ceiba 🌳🔬

  9. Intrinsic Cellular Responses of Human Wharton’s Jelly Mesenchymal Stem Cells Influenced by O2-Plasma-Modified and Unmodified Surface of Alkaline-Hydrolyzed 2D and 3D PCL Scaffolds 🔬⚙️

  10. Kluai Hom-Thong, biofermented solution, effective microorganism, banana, disease resistance 💡

Conclusion

Dr. Kewalin Inthanon is highly deserving of the Best Researcher Award. His innovative approach to research, combined with his impressive publication record, leadership in academia, and interdisciplinary expertise, make him an exceptional candidate. His focus on biotechnology, biochemistry, and natural products holds significant potential for advancing therapeutic and scientific advancements, particularly in the areas of aging, cancer, and stem cell research.

Dominique Heymann | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Dominique Heymann | Cancer Cell Biology | Best Researcher Award

Prof. Dr. Dominique Heymann , Nantes Université, CNRS, Institut de Cancérologie de l”Ouest , France

Professor Dominique Heymann is a highly esteemed academic and clinician, specializing in histology, embryology, and oncology. He is a Professor at Nantes University, France, and a Hospital Practitioner at the ICO Cancer Centre. With a wealth of experience in bone oncology and cancer research, he is also an Honorary Professor at the University of Sheffield, UK. His expertise spans from cell biology to immunology and biochemistry, and he is dedicated to advancing cancer research, particularly in the field of bone tumors and osteosarcoma. With numerous publications to his name and contributions to the global scientific community, Professor Heymann is recognized for his groundbreaking work in cell signaling and tumor progression. He is a valued researcher in the oncology community, with a strong focus on developing innovative therapies for cancer treatment.

Publication Profile:

Google Scholar

Strengths for the Award:

Professor Dominique Heymann is a distinguished figure in the field of oncology, particularly bone oncology, with a strong focus on the molecular mechanisms of bone tumors like osteosarcoma. His academic and clinical roles at the University of Nantes and the ICO Cancer Centre underscore his leadership in research and patient care. He has contributed significantly to understanding tumor biology, bone remodeling, and regenerative medicine, making him a highly respected expert in these fields. His research addresses crucial topics such as circulating tumor cells, targeted therapies, and the development of new anticancer agents, all of which are of immense value to advancing cancer treatment. With multiple publications in prestigious journals, including studies on novel therapies and molecular pathways in cancer progression, Professor Heymann has demonstrated exceptional scientific rigor. His global collaborations and recognition further establish him as a leading researcher in cancer biology and oncology.

Areas for Improvements:

Despite his numerous contributions, there are a few areas where Professor Heymann’s research could evolve. While he has made notable strides in cancer treatment and bone oncology, expanding research into more personalized medicine approaches and exploring the integration of AI and machine learning in predictive oncology could enhance the applicability of his findings. Furthermore, increasing collaborative efforts with international interdisciplinary teams could yield broader insights, especially in rare cancers and metastasis research. Developing a more extensive outreach to clinical trials and collaborations in broader regions may also allow for faster translation of his research into practice.

Education:

Professor Heymann began his academic journey at Paris VII University, where he earned a Master’s degree in Cell Biology in 1991. His PhD in Cell Biology and Immunology was completed at Nantes University in 1995, a pivotal moment in his career. Further expanding his knowledge, he pursued research management abilities and a deeper focus on Biochemistry and Cell Biology at Nantes University in 1998. He also received specialized certification in Histology from Nantes University in 1999 and later completed the required authorizations for animal experimentation in 2003 and 2016. Throughout his academic career, Professor Heymann has continually updated his qualifications, ensuring his expertise remains at the cutting edge of medical and biological sciences. His academic foundation has underpinned his significant contributions to cancer research, with a strong emphasis on bone oncology and regenerative medicine.

Experience:

Professor Dominique Heymann has an extensive and diverse career spanning several decades in both academic and clinical settings. Currently, he serves as a Professor of Histology/Embryology at Nantes University and as a Hospital Practitioner at the ICO Cancer Centre, where he is instrumental in patient care and research. His professional trajectory includes significant roles in oncology, particularly focused on bone tumors, osteosarcoma, and regenerative medicine. As an Honorary Professor at the University of Sheffield, he extends his influence beyond France, fostering international collaboration in cancer research. Professor Heymann has been a prominent figure in multiple research projects, having managed and contributed to groundbreaking studies. His expertise in cancer biology, combined with his academic roles, has allowed him to mentor students and researchers, shaping the next generation of scientists. His dual role in academia and clinical practice makes him a leading figure in both spheres.

Awards and Honors:

Professor Dominique Heymann’s career is adorned with numerous accolades and honors. As a tenured professor at the University of Nantes, he has received recognition for his contributions to histology, embryology, and oncology. He was appointed as an Honorary Professor in Bone Oncology at the University of Sheffield, UK, an esteemed acknowledgment of his expertise in the field. His work in cancer research, particularly related to bone tumors, has earned him international recognition, and his published studies continue to be highly regarded in scientific journals. Additionally, Professor Heymann has contributed significantly to the understanding of osteosarcoma and bone regeneration, which has earned him awards from academic and clinical societies. His continuous impact in advancing the field through groundbreaking research, leadership in clinical oncology, and educational contributions has made him a highly respected figure in the medical and scientific communities.

Research Focus:

Professor Dominique Heymann’s research is focused on cancer, particularly bone tumors such as osteosarcoma, and the molecular mechanisms involved in bone regeneration. His work primarily investigates the signaling pathways that control bone remodeling, the interactions between tumor cells and the microenvironment, and the role of immune responses in bone diseases. One of his key research interests is the development of targeted therapies to combat cancer progression, with a special emphasis on novel anticancer agents, including glycosaminoglycan-mimetic compounds derived from marine bacterial exopolysaccharides. In addition, Professor Heymann is dedicated to studying the role of circulating tumor cells as predictive markers for drug resistance and tumor progression. His expertise also includes stem cell therapies, autophagy in osteoblasts, and the potential for therapeutic applications in bone repair and regeneration. His research aims to improve patient outcomes through innovative approaches in cancer treatment and bone health.

Publications Top Notes:

  • Heymann D, Muñoz-Garcia J, Babuty A, et al. A new promising anticancer agent: a glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharide. Int J Biol Macromol. (in press) 🧬

  • Jacquot P, Muñoz-Garcia J, Léger A, et al. A multispecific checkpoint inhibitor Nanofitin with a fast tumor accumulation property and antitumor activity in immune competent mice. Biomolecules. (in press) 🔬

  • Yadav P, Heymann D, Prasad RN. Circulating tumor cells: a predictive marker for drug resistance and tumor progression. Front Oncol. (in press) 🔬

  • Muñoz-Garcia J, et al. Interleukin-34 orchestrates bone formation through its binding to Bone Morphogenic Proteins. Theranostics. 2025; 15(7):3185-3202. 🦴

  • Young RJ, et al. CIRCUS: CIRCUlating tumor cells in soft tissue Sarcoma – a short report. Cancer Drug Resist. 2022; 4:51. 💉

  • Oliver L, et al. Transcriptional landscape of the interaction of human mesenchymal stem cells with glioblastoma in bioprinted co-cultures. Stem Cell Res Ther. 2024; 15(1):424. 🧫

  • Cordova LA, et al. Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care? Osteoporos Int. 2024; 35(9):1677-1678. 🦷

  • Childs A, et al. A prospective observational cohort study for newly diagnosed patients in the UK: ICONIC study initial results. Cancers (Basel). 2024; 16(13):2351. 📊

  • Rey V, et al. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma. EBioMedicine. 2024; 102:105090. 🧬

  • Jubelin C, et al. Identification of MCM4 and PKRDC as new regulators of osteosarcoma cell dormancy based on 3D cultures. BBA Mol Cell Res. 2024; 1871:119660. 🧪

Conclusion:

Professor Dominique Heymann’s expertise in oncology, histology, and embryology positions him as an outstanding candidate for the Research for Best Researcher Award. His achievements in cancer research, particularly in bone tumors, and his contributions to advancing the understanding of tumor biology make him an exemplary figure. While there are areas to expand in terms of interdisciplinary collaborations and technological integration, his exceptional body of work and his dedication to both academic excellence and clinical practice make him a deserving candidate for this prestigious award.

Jinlin Song | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Jinlin Song | Tissue Engineering Regeneration | Best Researcher Award

Prof. Dr. Jinlin Song , The Affiliated Stomatological Hospital of Chongqing Medical University , China

Prof. Jinlin Song is the current Dean of the Affiliated Stomatological Hospital of Chongqing Medical University, China. With a distinguished career in the field of dentistry, he holds a BS, MS, and Ph.D. from West China Medical University. Prof. Song has extensive experience in orthodontics and tissue engineering, particularly focused on periodontal regeneration in diabetic patients. Throughout his career, he has held prominent positions, including Vice Dean and Director of the Orthodontics Department at his institution. He is a well-regarded member of multiple prestigious professional organizations, including the World Federation of Orthodontists and the International College of Dentists. Prof. Song has published 264 scientific papers, holds 32 patents, and has contributed significantly to advancements in maxillofacial tissue engineering and regenerative therapies.

Publication Profile: 

Scopus

Strengths for the Award:

Prof. Jinlin Song is an exceptional candidate for the Best Researcher Award due to his groundbreaking contributions to the field of maxillofacial tissue engineering and orthodontics. His work in periodontal tissue regeneration, particularly in diabetic patients, has been pivotal in advancing clinical therapies and addressing long-standing challenges. Prof. Song has a remarkable publication record, with 264 papers in SCI journals, and has been recognized with numerous prestigious awards, including the 2023 National Science and Technology Progress Award. Additionally, his innovative approach to bone repair and tissue regeneration using novel scaffolds and therapeutic techniques exemplifies his leadership in dental and medical research. His 32 published patents further highlight his ability to translate research into real-world solutions.

Areas for Improvement:

Although Prof. Song’s research portfolio is impressive, expanding his focus into more interdisciplinary collaborations—especially in the realms of digital dentistry and AI-based diagnostic tools—could enhance the broader impact of his work. Further collaboration with industry leaders in the development of dental technologies might also increase the practical application of his innovations.

Education:

Prof. Jinlin Song pursued his academic journey at West China Medical University, where he completed his BS in Stomatology (1991-1996). He then continued his studies at the same university, earning both his Master’s and Ph.D. in Stomatology (1996-2001). Afterward, Prof. Song advanced his research expertise as a postdoctoral fellow at the Sichuan University Post-Doctoral Research Station (2001-2003). These academic credentials laid the foundation for his subsequent groundbreaking work in orthodontics and maxillofacial tissue engineering. Prof. Song’s continuous pursuit of innovation and research excellence has made him an influential figure in his field, furthering the development of regenerative therapies for periodontal tissue and orthodontic treatments.

Experience:

Prof. Jinlin Song has over two decades of experience in dental research and education. He began his career at the Affiliated Stomatological Hospital of Chongqing Medical University, where he was appointed Vice Director of the Orthodontics Department (2003-2004) and later became the Director of the department (2005-2013). He then took on the role of Vice Dean at the institution from 2013 to 2022. In March 2023, he was appointed as Dean, overseeing the academic and research directions of the hospital. Prof. Song’s leadership is evident in his involvement in various national and international projects, awards, and collaborations in the areas of orthodontics, tissue engineering, and regenerative medicine. His extensive publication record and patent portfolio demonstrate his pivotal role in advancing dental science and clinical practices, particularly in periodontal tissue regeneration and orthodontic treatment.

Research Focus :

Prof. Jinlin Song’s primary research focus lies in maxillofacial tissue engineering, particularly in periodontal tissue regeneration and orthodontic treatment innovations. He has made significant strides in addressing the challenges of periodontal tissue regeneration, especially in diabetic patients, by exploring combined therapeutic approaches like low-intensity pulsed ultrasound and metformin. His team has developed innovative scaffolds, including filamentous proteins and decellular matrix scaffolds, which have been shown to effectively improve clinical outcomes in bone repair and tissue regeneration. Prof. Song is also dedicated to studying the interactions between tissue regeneration and biological processes such as inflammation and macrophage energy metabolism. His work has garnered numerous awards, including national and provincial science and technology prizes. The long-term impact of his research aims to bridge the gap in clinical therapies for periodontal regeneration and other oral health challenges.

Publications Top Notes:

  • Nanoparticles Encapsulating Antigenic Peptides Induce Tolerogenic Dendritic Cells in Situ for Treating Systemic Lupus Erythematosus 🦠

  • Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism ⚙️

  • Heavy Mechanical Force Decelerates Orthodontic Tooth Movement via Piezo1-Induced Mitochondrial Calcium Down-Regulation 🔧

  • Effectiveness Evaluation of a Serious Game for Dental Lost Wax Casting Training 🎮

  • Neutrophil Airfreighter Efficiently Delivers siRNA-Loaded Nanocomplex to Mononuclear Phagocytes for Inhibition of mtDNA-Induced Inflammation 📦

  • Convertible Hydrogel Injection Sequentially Regulates Diabetic Periodontitis 💉

  • Scale for Measuring Critical Thinking Ability for Dental Residents: A Development and Validation Study 📊

Conclusion:

Prof. Jinlin Song’s exceptional academic and research accomplishments make him a highly deserving candidate for the Best Researcher Award. His work has not only contributed to academic knowledge but has also led to tangible improvements in clinical practice, making a profound impact on oral health care, particularly in tissue regeneration and orthodontics. Prof. Song’s career serves as an inspiration for future researchers in the field.

 

 

 

Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Dr. Gary Chan , SUNY Upstate Medical University , United States

Dr. Gary Ching-Tao Chan is a distinguished professor in the Department of Microbiology and Immunology at SUNY Upstate Medical University, Syracuse, NY. He completed his Ph.D. in Immunology at the University of Alberta, Canada, under the supervision of Dr. Larry J. Guilbert. Dr. Chan’s research expertise lies in viral immunology, particularly in human cytomegalovirus (HCMV) and dengue virus (DENV). He has a robust research portfolio with numerous contributions to the field, focusing on viral-host interactions and immune modulation. His work has led to groundbreaking discoveries in HCMV pathogenesis, including viral modulation of autophagy and cell signaling pathways. Dr. Chan has held academic appointments at prestigious institutions, including Louisiana State University Health Science Center, where he contributed significantly to advancing viral immunology. His commitment to research excellence is reflected in his impactful publications and active grant support.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Prolific Research Contributions: Dr. Gary Chan has made significant contributions to the field of microbiology, particularly in the understanding of human cytomegalovirus (HCMV) and its complex interactions with the immune system. His work has been consistently published in top-tier peer-reviewed journals such as Journal of Virology, Antiviral Research, and mBio, highlighting his influence in virology.

  2. Innovative and High-Impact Research: Dr. Chan’s research addresses fundamental aspects of viral pathogenesis, focusing on viral-host interactions, immune modulation, and viral replication. His innovative exploration into the molecular mechanisms of HCMV, such as the modulation of mTORC1 and the role of host transcription factors like HSF1, is groundbreaking and provides valuable insights for potential therapeutic strategies. His studies have also demonstrated significant contributions in understanding how viruses, including HCMV and Dengue virus, alter host cell signaling pathways, making his work crucial in antiviral research.

  3. Successful Grant Support: Dr. Chan has received substantial funding for his research, including multiple NIH R01 grants. His current projects, such as targeting the nuclear HSF1 for anti-HCMV strategies, are promising avenues for the development of novel antiviral therapies, further solidifying his standing as a leading researcher in his field.

  4. Recognition by Peers and Journals: His work has been widely recognized by peers in the field, as evidenced by the Journal of Virology Editor’s Pick in 2024 and the Journal of Virology Spotlight Article of Significant Interest in 2020. These accolades underline the impact and relevance of his research.

  5. Mentorship and Academic Leadership: As a Professor at SUNY Upstate Medical University, Dr. Chan contributes significantly to the academic and professional development of students and colleagues alike. His role in shaping the next generation of researchers, combined with his leadership in the field, highlights his commitment to advancing science.

Areas for Improvement:

  1. Broader Impact Across Other Virus Families: While Dr. Chan’s research on HCMV is groundbreaking, exploring the broader spectrum of viral infections, including RNA viruses like SARS-CoV-2, could expand his impact across viral disease research. By diversifying his focus, he could address other significant public health threats, further enhancing the breadth of his research.

  2. Increased Interdisciplinary Collaboration: Although Dr. Chan has successfully collaborated with various experts in the field of virology, fostering interdisciplinary collaborations with researchers from fields such as bioinformatics, computational biology, and structural biology could accelerate the development of novel antiviral therapies and improve the understanding of viral mechanisms.

  3. Public Engagement and Communication: Dr. Chan’s impactful research is highly technical, and while it has contributed to the scientific community, increased efforts in communicating his findings to the broader public could help in promoting awareness of viral infections and their treatment. Public engagement through media, outreach programs, or collaborative projects with health organizations could amplify his work’s societal impact.

Education:

Dr. Gary Chan earned his Ph.D. in Immunology from the University of Alberta, Edmonton, Canada, from 1999 to 2005. His doctoral research focused on “Human cytomegalovirus-induced trophoblast apoptosis,” under the mentorship of Dr. Larry J. Guilbert in the Department of Medical Microbiology and Immunology. Following his Ph.D., Dr. Chan pursued postdoctoral training at Louisiana State University Health Science Center (2006–2011) in the Department of Microbiology and Immunology. Under the guidance of Dr. Andrew Yurochko, his postdoctoral research expanded his expertise in virology and immune modulation. Dr. Chan’s extensive academic background, coupled with his training in cutting-edge viral immunology, has laid the foundation for his pioneering work on viral-host interactions, particularly with human cytomegalovirus (HCMV), contributing to novel therapeutic strategies.

Experience:

Dr. Gary Chan is a Professor at the Department of Microbiology and Immunology at SUNY Upstate Medical University, a role he has held since 2023. Prior to this, he was an Associate Professor at the same department from 2018 to 2023. Dr. Chan has a wealth of experience in virology and immunology, with a focus on human cytomegalovirus (HCMV) and dengue virus (DENV). He has been instrumental in advancing research on the molecular mechanisms of viral infections and their impact on the host immune system. Dr. Chan’s academic journey includes several years of postdoctoral training at Louisiana State University, where he contributed to significant findings in viral replication and immune responses. With a comprehensive background in molecular virology, cell biology, and immunology, Dr. Chan is recognized for his expertise in viral pathogenesis and therapeutic research.

Awards and Honors:

Dr. Gary Chan has received numerous prestigious awards and recognitions for his research excellence. In 2024, his publication, Human cytomegalovirus modulates mTORC1 to redirect protein translation within quiescently infected monocytes, was selected as an Editor’s Pick by the Journal of Virology. Additionally, his article on HCMV-induced autophagy preventing necroptosis of infected monocytes was featured as a Spotlight Article of Significant Interest in 2020. His innovative research has earned him continuous recognition within the virology community, including numerous peer-reviewed publications. Dr. Chan’s research contributions have also attracted substantial NIH grant support, including an R01 from the NIAID, to explore novel anti-HCMV strategies targeting nuclear HSF1. His scholarly achievements, including the successful funding of multi-year research projects, underscore his dedication to advancing our understanding of viral diseases and their immune modulation.

Research Focus:

Dr. Gary Chan’s research primarily focuses on viral immunology, specifically human cytomegalovirus (HCMV) and dengue virus (DENV). His work explores how these viruses manipulate host cellular processes, such as signaling pathways and immune responses, to promote viral replication and persistence. One of his major research areas is investigating the interactions between HCMV and monocytes, particularly how the virus modulates autophagy and apoptosis to avoid immune detection and promote its survival. Additionally, Dr. Chan’s research delves into the role of host transcription factors, such as HSF1, in regulating viral replication. His innovative work also involves creating bioswitches through protein and DNA engineering to combat HCMV. Through these projects, Dr. Chan aims to identify novel therapeutic targets to limit viral infections and improve antiviral strategies. His work is pivotal in advancing the understanding of how viral infections impact the host immune system and contribute to disease pathogenesis.

Publications Top Notes:

  1. Targeting HSF1 prevents HCMV replication 🦠

  2. DENV infection induces differential immunotranscriptomic profiles 🦟

  3. B cell receptor enhancement of dengue virus infection 🧬

  4. Virion-associated US28 modulates Akt activity in monocytes 💉

  5. The harms of promoting the leak lab hypothesis for SARS-CoV-2 🧫

  6. HCMV modulates mTORC1 in infected monocytes 💪

  7. Virology – The path forward 🔬

  8. Inhibition of SIRT2 promotes HCMV-infected monocyte death ⚔️

  9. Virology under the Microscope – A call for rational discourse 📚

  10. Modulation of host cell signaling in HCMV latency 🧪

Conclusion:

Dr. Gary Ching-Tao Chan is highly deserving of the Best Researcher Award due to his outstanding contributions to the field of virology, particularly in the area of human cytomegalovirus and its interaction with the immune system. His innovative research has shaped the understanding of viral pathogenesis, leading to potential therapeutic breakthroughs. With significant funding, prestigious recognition, and a strong academic presence, Dr. Chan continues to push the boundaries of scientific knowledge. While there are opportunities for expansion into other viral research areas and greater public outreach, his accomplishments make him a leading figure in microbiology and an excellent candidate for this award.

Doaa Esmaeil | Cancer treatment | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Doaa Esmaeil | Cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Doaa Esmaeil , Mansoura university , Egypt

Dr. Doaa Abd Elmoneim Mohamed Esmaeil is an Associate Professor of Oral Pathology at Mansoura University, Egypt. She is a dedicated researcher focused on oral diseases, particularly in understanding their pathogenesis, molecular biology, and carcinogenesis. With a strong background in oral pathology, she has contributed to numerous studies and publications that explore various aspects of oral health, including cancer research and therapeutic strategies. Dr. Esmaeil’s research includes innovative work on the effects of different agents and treatments in combating oral diseases. Her extensive academic contributions have established her as a prominent figure in the field of oral pathology, both in Egypt and internationally. She is committed to advancing the understanding of oral diseases, particularly those linked to cancer, and plays an active role in advancing the knowledge of oral health practices.

Publication Profile:

Orcid

Strengths for the Award:

  1. Academic Excellence: Dr. Doaa Esmaeil is an Associate Professor in the Oral Pathology Department at Mansoura University, Egypt, with a strong academic background and expertise in oral diseases, particularly oral carcinogenesis and molecular biology. Her contributions to the scientific community through both teaching and research have made her a significant figure in the field.

  2. Research Contributions: Dr. Esmaeil has made notable contributions to oral pathology through her innovative research on molecular mechanisms in oral diseases, focusing on cancer pathogenesis, therapeutic agents, and disease prevention. Her research projects, such as exploring the efficacy of phytomedicines against chemotherapy-induced toxicity, demonstrate her commitment to improving therapeutic outcomes.

  3. International Recognition: She has published several papers in high-impact journals such as the European Journal of Dentistry, Saudi Dental Journal, and the Egyptian Dental Journal, showcasing her widespread impact in the field of oral pathology.

  4. Ongoing Contributions to the Field: Dr. Esmaeil’s research is forward-thinking, addressing cutting-edge topics like stem cells in oral cancer therapy, the role of molecular markers in oral diseases, and enhancing chemotherapeutic efficacy against head and neck cancers.

Areas for Improvement:

  1. Citation Impact: While Dr. Esmaeil has been an active researcher with publications in reputed journals, her citation index of 3, while a good start, could benefit from increased visibility and collaborations with larger research networks to elevate her work’s recognition and citation in the broader academic community.

  2. Industry Collaborations: Although Dr. Esmaeil’s academic and research work is notable, there appears to be limited documented collaboration with industry projects or patents. Strengthening connections with industry could help translate her research into practical applications, potentially enhancing the impact of her work.

  3. Multidisciplinary Collaboration: While Dr. Esmaeil has collaborated with researchers within the field of oral pathology, expanding these collaborations into multidisciplinary domains could provide a more comprehensive approach to her research and open new avenues for funding and innovation.

Education:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil earned her Bachelor’s degree in Dental Medicine from Mansoura University, Egypt. She then pursued her Master’s and Ph.D. degrees in Oral Pathology, also from Mansoura University, where she developed a keen interest in the molecular mechanisms of oral diseases. Her academic journey has been enriched by her work on various research projects exploring oral carcinogenesis, molecular biology, and the development of therapeutic strategies for oral cancers. Dr. Esmaeil’s dedication to research and her extensive educational background have established her as an expert in oral pathology. She has participated in numerous international and national conferences, strengthening her expertise in both academic and clinical settings. Her education and commitment to continuous learning have shaped her approach to understanding and treating oral diseases, and she remains an influential educator and researcher at Mansoura University.

Experience:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil has over a decade of experience in teaching and researching in the field of oral pathology. As an Associate Professor in the Oral Pathology Department at Mansoura University, she has played a pivotal role in educating undergraduate and postgraduate students in both theoretical and practical aspects of oral pathology. Her experience extends to leading numerous research projects in oral diseases, with a special focus on oral cancer, its molecular mechanisms, and therapeutic approaches. Dr. Esmaeil’s work on tissue biomarkers, cancer stem cells, and chemotherapeutic agents has been recognized internationally. Additionally, her role as a reviewer for several scientific journals has solidified her standing as a respected authority in oral pathology. Her collaborative projects with other universities and institutions, both local and international, have further enhanced her research expertise. Dr. Esmaeil’s passion for education and research continues to shape the future of oral pathology.

Research Focus:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil’s research primarily focuses on the molecular pathogenesis of oral diseases, with a particular emphasis on oral cancer. Her work explores the complex mechanisms underlying carcinogenesis in the oral cavity, particularly focusing on the molecular markers, cell lines, and signaling pathways involved in cancer progression. Dr. Esmaeil is also interested in developing innovative therapeutic strategies for oral diseases, with research exploring the efficacy of various agents, including phytomedicines and synthetic compounds, against oral cancer and other related disorders. Her ongoing research examines the effectiveness of combining traditional treatments with new molecular-targeted therapies to improve patient outcomes. Additionally, she has investigated the role of cancer stem cells in therapy resistance and the development of new treatment modalities. Dr. Esmaeil’s research contributes to the broader understanding of oral diseases, aiming to improve both prevention and treatment options for conditions like oral squamous cell carcinoma.

Publication Top Notes:

  • The Impact of Silver Diamine Fluoride and Potassium Iodide Treatment on Microtensile Bonds Strength of Composite Restoration for Carious Dentin in Primary and Permanent Teeth and Its Potential Color Changes: An in Vitro Study 📄🦷

  • Antitumoral properties of the pomegranate peel and blueberry extracts against tongue carcinoma (in vitro study) 🍊🍇🦷

  • Oral squamous cell carcinoma Immunohistochemical Expression of PD L1 in Oral Epithelial Dysplasia 🦷🔬

  • Stem Cell Marker as A Factor for The Different Biological Behavior of Ameloblastoma and Odontogenic Keratocyst 🧬🦷

  • Diagnostic Value of Nuclear Receptor Subfamily 4 Group A Member 3 in Salivary Gland Carcinomas 🔬🦷

  • The controversial role of MDM2, MCM3 and Bcl-X in Ameloblastoma and Ameloblastic Carcinoma: An update 🧬🦷

  • Pomegranate molasses and red grape vinegar: can they alleviate dysplastic changes in chemically induced oral squamous cell carcinoma in hamsters? 🍑🍇🦷

  • Tumor stroma ratio as a parameter for prognosis and clinicopathological behavior of oral squamous cell carcinoma: A retrospective cohort study 📊🦷

  • Emerging therapeutic modality enhancing the efficiency of chemotherapeutic agents against head and neck squamous cell carcinoma cell lines 💊🦷

  • Angiogenesis and mast cells as predictive factors in behavior of Odontogenic cysts 🌱🦷

Conclusion:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil is highly deserving of the Best Researcher Award. Her academic excellence, profound contributions to oral pathology, and commitment to advancing the understanding of oral diseases and cancer pathogenesis make her a strong candidate. By focusing on broadening her citation impact and enhancing her industry collaborations, Dr. Esmaeil has the potential to elevate her career to even greater heights. Her continued research and dedication to the scientific community position her as an influential researcher in the field of oral pathology, contributing not only to academia but also to real-world applications in oral healthcare.